December 9th, 2011

FDA panel wants more risk information on Yaz pills

By MATTHEW PERRONE
Associated Press

Federal health experts said Thursday that drug labeling for Yaz and other widely-used birth control pills should be updated to emphasize recent data suggesting a higher risk of blood clots with the drugs than older contraceptive pills.

The Food and Drug Administration’s panel of experts voted 21-5 Thursday that labeling on the popular drugs made by Bayer is inadequate and needs more information about the potential risk of blood clots in the legs and lungs.

Read more: http://bit.ly/sP1WsA

Comments

Add your own Comment

(optional)